Fungal Infections

Published on 10/02/2015 by admin

Filed under Emergency Medicine

Last modified 10/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1158 times

176 Fungal Infections

General Epidemiology

The risk of fungal infections is tied to both geography and immune status. Immunocompromised individuals are exponentially more likely to suffer from fungal infection. Immunocompetent patients do acquire significant, often invasive fungal disease, especially in endemic areas. In 3 counties in the southwestern United States, coccidioidomycosis in immunocompetent patients who were more 65 years old occurred with an incidence of 40 in 100,000. In addition to the best-known endemic areas, smaller areas in Africa and Asia are known to harbor pockets with high rates of infection. Fungal infections are a scourge in hospitals, and they account for significant numbers of nosocomial infections. Previously published data showed that 10% of all nosocomial infections were fungal,1 and Candida was responsible for 85% of those infections.2

Presenting Signs and Symptoms

No specific presenting signs or symptoms are pathognomonic of fungal infection. Certain patient populations are more likely to contract fungal infections (Table 176.1).

Table 176.1 Predisposing Factors in Fungal Infections

PATIENT RISK FACTOR COMMON FUNGAL INFECTION
Human immunodeficiency virus infection (acquired immunodeficiency syndrome) Candidiasis, cryptococcosis, aspergillosis
Recent organ transplantation Candidiasis, aspergillosis
Neutropenia Candidiasis, aspergillosis
High-dose steroids Zygomycosis, candidiasis
Recent antibiotic treatment Candidiasis
Diabetes Candidiasis, zygomycosis
Recent or ongoing hospitalization Candidiasis, aspergillosis
Recent abdominal surgery or burns (especially with intensive care unit stay) Candidiasis
Travel to endemic area Histoplasmosis, blastomycosis, coccidioidomycosis

Depending on the site of infection, presenting symptoms vary. The important signs of fungal infection are indicated by indirect evidence found in the patient’s history. Patients who have a history suggestive of greater risk for fungal infection should be evaluated and treated more extensively. For example, when a patient with acquired immunodeficiency syndrome (AIDS) presents to the emergency department (ED) after a recent admission for pneumonia with recurrent symptoms of pneumonia, the incidence of fungal infection, specifically Candida, is much higher. The patient needs cultures specifically for Candida and requires prompt antifungal therapy in the ED, in addition to broad-spectrum antibiotics covering health care–associated pneumonia.

Organ-Specific Clinical Findings

Sepsis

Fungal sepsis is rare, but it is highly fatal. The Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial4 demonstrated a fungal sepsis mortality rate of nearly 56% that was more than double the nonfungal sepsis mortality rate of 28% to 30%. Suspicion is necessary to identify these patients early. A patient with a history of recent hospitalization, immunosuppression from organ transplants, or abdominal surgery has a dramatically increased risk of disseminated fungal infection causing sepsis. Cultures with specific fungal organism media should be sent, followed by initiation of antifungal therapy.

Cutaneous Disorders

The most common fungal infections in humans are the superficial cutaneous fungal infections (e.g., tinea), which are detailed in Chapter 184. Certain fungal species may start as cutaneous lesions and disseminate to invasive disease, or they may begin as pulmonary disease and disseminate to form cutaneous lesions. The latter type is a form of blastomycosis characterized by a primary pulmonary infection that spreads, leading to cutaneous lesions in 75% of patients with disseminated disease. Sporotrichosis behaves similarly, but in an opposite fashion, because most patients with disseminated disease initially have cutaneous lesions. Both infections manifest as raised verrucous lesions with irregular borders that are painless and are often seen on the face or neck. Either infection can develop into the verrucous form or can become an extremity ulcer. Potassium hydroxide (KOH) scraping identifies these lesions as fungal.

Specific Fungal Infections

Blastomycosis

Blastomycosis is caused by the fungus Blastomyces dermatitidis. This infection occurs primarily in healthy individuals who are exposed in one of the endemic areas (Table 176.2). Pulmonary infections are typical, especially in the acute phase, and are contracted though inhalation of the dormant form. After attaining body temperature, the organism transforms into the yeast form and develops a greater ability to infect. Many patients acquire the infection and have chronic pneumonia for years, often diagnosed as reactive airway disease, before the infection is discovered. Patients with chronic pulmonary infections often develop extrapulmonary manifestations of the disease. These patients frequently have cutaneous lesions, and frank meningitis occurs in 10% of disseminated cases. If CNS involvement is suspected, a simple lumbar puncture is inadequate because results are routinely negative; ventricular fluid collection is required to confirm the diagnosis.

Table 176.2 Endemic Areas of Common Fungi

FUNGUS ENDEMIC AREA
Coccidioides Southwestern United States
Blastomyces Mississippi, St. Lawrence, and Ohio River valleys
Histoplasma Mississippi and Ohio River valleys